Selected Publications
ZMB Publications
Selected Publications
The list provides selected publications of the ZMB from 2004 to 2021, published in the journals listed below.
You can narrow the list down by year and author. If an error accured or no data was found, please reload or reset the page.
(View all ZMB publications via the interface of the university bibliography).
Journals
- ACS Nano
- Acta Neuropathologica
- Advanced Drug Delivery Reviews
- All Nature Journals
- American Journal of Human Genetics
- Angewandte Chemie International Edition
- Annals of Oncology
- Annual Review of Biochemistry
- Annual Review of Genetics
- Annual Review of Microbiology
- Biomaterials
- Biotechnology Advances
- Blood
- Brain
- Cancer Cell
- Cancer Discovery
- Cancer Research
- Cell
- Cell Clinical Cancer Research
- Cell Reports
- Chemical Reviews
- Chemical Society Reviews
- Circulation
- Circulation Research
- Current Biology
- eLife
- EMBO Molecular Medicine
- EMBO Reports
- Endocrine Reviews
- European Heart Journal
- FEMS Microbiology Reviews
- Gastroenterology
- Genes and Development
- Gut
- Hepatology
- Immunity
- Immunological Reviews
- JAMA: Journal of the American Medical Association
- JAMA Oncology
- JAMA Neurology
- Journal of Hepatology
- Journal of the American Chemical Society
- Journal of the American Medical Association
- Journal of Clinical Oncology
- Journal of Hepatology
- Lancet
- Leukemia
- Molecular Cell
- Molecular Psychiatry
- Natural Product Research
- Nature
- Nature Biotechnology
- Nature Chemical Biology
- Nature Communications
- Nature Genetics
- Nature Medicine
- Nature Methods
- Nature Nanotechnology
- Nature Reviews Molecular Cell Biology
- Nature Reviews Neurology
- Nature Structural & Molecular Biology
- Neuro-Oncology
- Nucleic Acids Research
- Proceedings of the National Academy of Sciences of the United States of America Science
- Science
- Science Advances
- The British Journal of Cancer
- The EMBO Journal
- The Journal of Cell Biology
- The Lancet
- The Lancet Diabetes and Endocrinology
- The Lancet Gastroenterology & Hepatology
- The Lancet Infectious Diseases
- The Lancet Neurology
- The Lancet Oncology
- The New England Journal of Medicine
- Trends in Neurosciences
- Trends in Pharmacological Sciences
There were 1000 publications found
-
Günter Wulff (1935 –2023) : Father of Molecular ImprintingIn: Angewandte Chemie International Edition Vol. 63 (2024) Nr. 12, e202402244Online Full Text: dx.doi.org/ (Open Access)
-
TopBP1 utilises a bipartite GINS binding mode to support genome replicationIn: Nature Communications Vol. 15 (2024) Nr. 1, 1797Online Full Text: dx.doi.org/; Online Full Text: dx.doi.org/ (Open Access)
-
Structure of the human KMN complex and implications for regulation of its assemblyIn: Nature Structural & Molecular Biology Vol. 31 (2024) Nr. 6, pp. 861 - 873Online Full Text: dx.doi.org/ (Open Access)
-
Evolutionary trajectories of small cell lung cancer under therapyIn: Nature Vol. 627 (2024) Nr. 8005, pp. 880 - 889Online Full Text: dx.doi.org/ (Open Access)
-
A validation strategy to assess the role of phase separation as a determinant of macromolecular localizationIn: Molecular Cell Vol. 84 (2024) Nr. 9, pp. 1783 - 1801.e7Online Full Text: dx.doi.org/ (Open Access)
-
Neoadjuvant nivolumab with or without relatlimab in resectable non-small-cell lung cancer : A randomized phase 2 trialIn: Nature Medicine Vol. 30 (2024) Nr. 6, pp. 1602 - 1611Online Full Text: dx.doi.org/ (Open Access)
-
Cell-mediated cytotoxicity within CSF and brain parenchyma in spinal muscular atrophy unaltered by nusinersen treatmentIn: Nature Communications Vol. 15 (2024) Nr. 1, 4120Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
iSERS : from nanotag design to protein assays and ex vivo imagingIn: Chemical Society Reviews Vol. 53 (2024) Nr. 13, pp. 6675 - 6693Online Full Text: dx.doi.org/ (Open Access)
-
Ripretinib versus sunitinib in gastrointestinal stromal tumor : ctDNA biomarker analysis of the phase 3 INTRIGUE trialIn: Nature Medicine Vol. 30 (2024) Nr. 2, pp. 498 - 506Online Full Text: dx.doi.org/ (Open Access)
-
Microtubule end-on attachment maturation regulates Mps1 association with its kinetochore receptorIn: Current Biology Vol. 34 (2024) Nr. 11, pp. 2279 - 2293.e6Online Full Text: dx.doi.org/ (Open Access)
-
A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanomaIn: Cell Vol. 187 (2024) Nr. 1, pp. 166 - 183.e25Online Full Text: dx.doi.org/ (Open Access)
-
Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRAIn: Nature Communications Vol. 15 (2024) Nr. 1, 63Online Full Text: dx.doi.org/ (Open Access)
-
XPO1-Mediated mRNA Export of Genome Maintenance Regulators Drives Chemotherapy Resistance in Aggressive LymphomaIn: Cancer Research Vol. 84 (2024) Nr. 1, pp. 3 - 5Online Full Text: dx.doi.org/
-
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAIn: Blood Vol. 143 (2024) Nr. 6, pp. 522 - 534Online Full Text: dx.doi.org/
-
Thirty years of structural changesIn: Nature Structural & Molecular Biology Vol. 31 (2024) Nr. 1, pp. 4 - 5Online Full Text: dx.doi.org/
-
VCF1 is a p97/VCP cofactor promoting recognition of ubiquitylated p97-UFD1-NPL4 substratesIn: Nature Communications Vol. 15 (2024) Nr. 1, 2459Online Full Text: dx.doi.org/ (Open Access)
-
Lysosomal damage sensing and lysophagy initiation by SPG20-ITCHIn: Molecular Cell (2024) pp. 1556 - 1569.e10Online Full Text: dx.doi.org/ (Open Access)
-
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophyIn: Acta Neuropathologica Vol. 147 (2024) Nr. 1, 53Online Full Text: dx.doi.org/ (Open Access)
-
An atlas of cells in the human tonsilIn: Immunity Vol. 57 (2024) Nr. 2, pp. 379 - 399.e18Online Full Text: dx.doi.org/ (Open Access)
-
De novo and salvage purine synthesis pathways across tissues and tumorsIn: Cell Vol. 187 (2024) Nr. 14, pp. 3602 - 3618.e20Online Full Text: dx.doi.org/
-
N-Cyanopiperazines as Specific Covalent Inhibitors of the Deubiquitinating Enzyme UCHL1In: Angewandte Chemie International Edition Vol. 63 (2024) Nr. 12, e202318849Online Full Text: dx.doi.org/ (Open Access)
-
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III MelanomaIn: The New England Journal of Medicine (2024) in pressOnline Full Text: dx.doi.org/
-
Rational correction of pathogenic conformational defects in HTRA1In: Nature Communications Vol. 15 (2024) Nr. 1, 5944Online Full Text: dx.doi.org/ (Open Access)
-
Amivantamab plus lazertinib versus osimertinib in first-line EGFR-mutant advanced non-small-cell lung cancer with biomarkers of high-risk disease : a secondary analysis from MARIPOSAIn: Annals of Oncology Vol. 35 (2024) Nr. 9, pp. 805 - 816Online Full Text: dx.doi.org/ (Open Access)
-
Short-term post-fast refeeding enhances intestinal stemness via polyaminesIn: Nature (2024) in pressOnline Full Text: dx.doi.org/
-
Cranioencephalic functional lymphoid units in glioblastomaIn: Nature Medicine (2024) in pressOnline Full Text: dx.doi.org/ (Open Access)
-
tracerDB : a crowdsourced fluorescent tracer database for target engagement analysisIn: Nature Communications Vol. 15 (2024) Nr. 1, 5646Online Full Text: dx.doi.org/ (Open Access)
-
Cardiac wasting and cancerIn: European Heart Journal Vol. 45 (2024) Nr. 34, pp. 3135 - 3137Online Full Text: dx.doi.org/ (Open Access)
-
Role of protein kinase PLK1 in the epigenetic maintenance of centromeresIn: Science Vol. 385 (2024) Nr. 6713, pp. 1091 - 1097Online Full Text: dx.doi.org/
-
BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathwayIn: Science Advances Vol. 10 (2024) Nr. 36, eadn9361Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054) : Long-term, health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trialIn: The Lancet Oncology Vol. 25 (2024) Nr. 9, pp. 1202 - 1212Online Full Text: dx.doi.org/
-
Directionality of HLA-DP permissive mismatches improves risk prediction in HCT for acute leukemia and MDSIn: Blood (2024) in pressOnline Full Text: dx.doi.org/
-
A modular DNA origami nanocompartment for engineering a cell-free, protein unfolding and degradation pathwayIn: Nature Nanotechnology Vol. 19 (2024) Nr. 10, pp. 1521 - 1531Online Full Text: dx.doi.org/ (Open Access)
-
Routine extracorporeal life support in infarct-related cardiogenic shock : 1-year results of the ECLS-SHOCK trialIn: European Heart Journal Vol. 45 (2024) Nr. 39, pp. 4200 - 4203Online Full Text: dx.doi.org/ (Open Access)
-
The journey to understand previously unknown microbial genesIn: Nature Vol. 626 (2024) Nr. 7998, pp. 267 - 269Online Full Text: dx.doi.org/ (Open Access)
-
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION) : a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialIn: Lancet Vol. 403 (2024) Nr. 10445, pp. 2709 - 2719Online Full Text: dx.doi.org/
-
Clinical Benefit of Avapritinib in KIT-Mutant Gastrointestinal Stromal Tumors : A Post Hoc Analysis of the Phase I NAVIGATOR and Phase I/II CS3007-001 StudiesIn: Clinical Cancer Research Vol. 30 (2024) Nr. 4, pp. 719 - 728Online Full Text: dx.doi.org/
-
Coinhibition of topoisomerase 1 and BRD4-mediated pause release selectively kills pancreatic cancer via readthrough transcriptionIn: Science Advances Vol. 9 (2023) Nr. 41, eadg5109Online Full Text: dx.doi.org/ (Open Access)
-
Germ line variant GFI1-36N affects DNA repair and sensitizes AML cells to DNA damage and repair therapyIn: Blood Vol. 142 (2023) Nr. 25, pp. 2175 - 2191Online Full Text: dx.doi.org/ (Open Access)
-
Transcriptional reprogramming by mutated IRF4 in lymphomaIn: Nature Communications Vol. 14 (2023) Nr. 1, 6947Online Full Text: dx.doi.org/ (Open Access)
-
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and PentamerIn: Immunity Vol. 56 (2023) Nr. 11, pp. 2602 - 2620.e10Online Full Text: dx.doi.org/
-
Integrative multi-omics reveals two biologically distinct groups of pilocytic astrocytomaIn: Acta Neuropathologica Vol. 149 (2023) Nr. 4, pp. 551 - 564Online Full Text: dx.doi.org/ (Open Access)
-
Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patientsIn: Nature Communications Vol. 14 (2023) Nr. 1, 2835Online Full Text: dx.doi.org/ (Open Access)
-
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O) : disease-free survival results from a randomised, open-label, phase 2 trialIn: Lancet Vol. 402 (2023) Nr. 10404, pp. 798 - 808Online Full Text: dx.doi.org/
-
Comprehensive molecular characterization of mitochondrial genomes in human cancersIn: Nature Genetics Vol. 52 (2023) pp. 342 - 352Online Full Text: dx.doi.org/ (Open Access)
-
Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencingIn: Nature Genetics Vol. 52 (2023) pp. 331 - 341Online Full Text: dx.doi.org/ (Open Access)
-
Marine viruses disperse bidirectionally along the natural water cycleIn: Nature Communications Vol. 14 (2023) Nr. 1, 6354Online Full Text: dx.doi.org/ Online Full Text (Open Access)
-
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized TrialIn: Clinical Cancer Research Vol. 29 (2023) Nr. 17, pp. 3313 - 3319Online Full Text: dx.doi.org/ (Open Access)
-
Disruption of chromatin folding domains by somatic genomic rearrangements in human cancerIn: Nature Genetics Vol. 52 (2023) Nr. 3, pp. 294 - 305Online Full Text: dx.doi.org/ (Open Access)
-
Extracorporeal Life Support in Infarct-Related Cardiogenic ShockIn: The New England Journal of Medicine Vol. 389 (2023) Nr. 14, pp. 1286 - 1297Online Full Text: dx.doi.org/